FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20220321E00344
1. Date of relevant event: 17/03/2022
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06996
4. Name of listed corporation: Antengene Corporation Limited 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 664,383,144
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Mei
(Other names) Jay
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1702Miscellaneous
Notice filed to remove outdated information (if you select this Code you must state the outdated information in the Supplementary Information box and identify the box which contains the updated information)
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 
         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position180,597,99427.18
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position180,597,99427.18
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position4,670,000
2301Trustee
Long position175,927,994
2305Beneficiary of a trust (other than a discretionary interest)
Long position175,927,994
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4101Listed derivatives - Physically settled
19/11/202222/08/2030  USD0.920  4,000,000
Long position
4101Listed derivatives - Physically settled
27/08/202326/08/2031  HKD12.560  268,000
Long position
4101Listed derivatives - Physically settled
27/08/202426/08/2031  HKD12.560  201,000
Long position
4101Listed derivatives - Physically settled
27/08/202526/08/2031  HKD12.560  201,000
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
JAY MEI 2020 GRATN/AJay Mei100.00N
Long position175,927,994
JAY MEI 2022 GRATN/AJay Mei100.00N
Long position0
AM & Beyond TrustN/AJay Mei100.00N
Long position0
Meiland Pharma Tech SPCSertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)JAY MEI 2020 GRAT56.39Y
Long position175,927,994
Meiland Pharma Tech SPCSertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)JAY MEI 2022 GRAT18.61Y
Long position175,927,994
Meiland Pharma Tech SPCSertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)AM & Beyond Trust8.52Y
Long position175,927,994
Meiland Pharma Tech SPCSertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Jay Mei16.48Y
Long position175,927,994
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
JAY MEI 2020 GRATAddresses of individuals are not displayed.
5101Trustee of a trust
Long position175,927,994
JAY MEI 2020 GRATAddresses of individuals are not displayed.
5102Beneficiary of a trust (other than a discretionary interest)
Long position175,927,994
JAY MEI 2022 GRATAddresses of individuals are not displayed.
5101Trustee of a trust
Long position0
JAY MEI 2022 GRATAddresses of individuals are not displayed.
5102Beneficiary of a trust (other than a discretionary interest)
Long position0
AM & Beyond TrustAddresses of individuals are not displayed.
5102Beneficiary of a trust (other than a discretionary interest)
Long position0
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Completion of a share transfer of Meiland Pharma Tech SPC took place on 17 March 2022. Information in Box 30 is updated to reflect the shareholding of Meiland Pharma Tech SPC after the completion of the said share transfer.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 21/03/2022
(dd/mm/yyyy)